Heteroresistance to colistin in wild-type Klebsiella pneumoniae isolates from clinical origin

Abstract

ABSTRACT Heteroresistance to colistin can be defined as the presence of resistant subpopulations in an isolate that is susceptible to colistin. The aim of this work was to study heteroresistance in 10 wild-type Klebsiella pneumoniae isolates of clinical origin, to determine the importance of persisters variants and stable mutants in heteroresistance, and to describe genomic changes observed in mutants obtained in population analysis profiling (PAP) assays. Mutations in genes related to colistin resistance (including pmr A, pmr B, pmr C, pmr D, pho P, pho Q, crr A, ccr B, mgr B, ram A, rom A, lax A, lpx C, lpx D, acr A, and acr B) were investigated by whole-genome sequencing with an Illumina platform. Additionally, PCR and Sanger sequencing of the mgr B gene of the selected mutants were also performed. PAP showed that the investigated K. pneumoniae isolates present heteroresistance to colistin, which is related to both the growth of persisters variants and the selection of resistant mutants. A total of 31-point mutations were identified in proteins PhoP, PhoQ, PmrB, and CrrB of which novel mutations were reported in PhoP (E22K, L12Q, and M175K), PhoQ (V24G and L105Q), PmrB (G207D), and CrrB (G183V). MgrB changes included amino acid substitutions (D31N and L19R), deletions (∆C28, ∆C39, ∆Q22, and ∆W6) or the presence of insertion sequences belonging to the IS1 (ISKpn14) and IS5 (ISKpn74) families that inactivated the gene. The results of this study will help to understand the mechanisms involved in colistin heteroresistance among wild-type K. pneumoniae isolates. IMPORTANCE Colistin is one of the last remaining therapeutic options for dealing with Enterobacteriaceae. Unfortunately, heteroresistance to colistin is also rapidly increasing. We described the prevalence of colistin heteroresistance in a variety of wild-type strains of Klebsiella pneumoniae and the evolution of these strains with colistin heteroresistance to a resistant phenotype after colistin exposure and withdrawal. Resistant mutants were characterized at the molecular level, and numerous mutations in genes related to lipopolysaccharide formation were observed. In colistin-treated patients, the evolution of K. pneumoniae heteroresistance to resistance phenotype could lead to higher rates of therapeutic failure.